Equities

Biotricity Inc

BTCY:QBB

Biotricity Inc

Actions
  • Price (USD)0.32
  • Today's Change0.02 / 6.67%
  • Shares traded32.95k
  • 1 Year change-85.32%
  • Beta1.3570
Data delayed at least 15 minutes, as of Sep 20 2024 20:52 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments0.790.5712
Total Receivables, Net1.811.812.41
Total Inventory1.882.340.84
Prepaid expenses------
Other current assets, total------
Total current assets4.474.7215
Property, plant & equipment, net1.241.611.27
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term0.230.180.09
Other long term assets------
Total assets5.946.5117
LIABILITIES
Accounts payable5.223.441.16
Accrued expenses4.831.941.65
Notes payable/short-term debt9.244.771.54
Current portion long-term debt/capital leases2.40----
Other current liabilities, total1.011.010.52
Total current liabilities23114.87
Total long term debt111312
Total debt221814
Deferred income tax------
Minority interest------
Other liabilities, total2.362.151.47
Total liabilities362619
SHAREHOLDERS EQUITY
Common stock0.010.050.05
Additional paid-in capital969392
Retained earnings (accumulated deficit)(127)(113)(93)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.30(0.13)(0.67)
Total equity(30)(20)(2.14)
Total liabilities & shareholders' equity5.946.5117
Total common shares outstanding9.518.758.55
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.